Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE plus vitamin K2 vs TACE alone in hepatocellular carcinoma (TACEVK)
jRCTs051180115Phase 2Completed
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of menaquinone in hepatocellular carcinoma (HCC) (2 arms). Primary endpoint: Treatment effect of TACE. Started Apr 2017; status: completed.
02
Drugs
menaquinone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCTs051180115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180115.